Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reporting.

Brain pathology (Zurich, Switzerland)·2026
Same author

Impact of scan duration and scatter correction on quantitative accuracy in Yttrium-90 PET/CT imaging using LAFOV and SAFOV systems: a phantom and clinical evaluation.

EJNMMI physics·2026
Same author

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Nature cancer·2026
Same author

Divergent scalp-to-region distance alteration patterns in autism spectrum disorders, Parkinson's disease and Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same author

Rapid polymer-based immunohistochemistry for intraoperative CNS tumor diagnosis: A validation study.

Clinical neuropathology·2026
Same author

Subtype-specific prognostic impact of TNIK in medulloblastoma.

Journal of neuro-oncology·2026

Related Experiment Video

Updated: Aug 23, 2025

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.6K

Multiparametric Characterization of Intracranial Gliomas Using Dynamic [18F]FET-PET and Magnetic Resonance

Thomas Pyka1,2,3, Iwona Krzyzanowska4, Axel Rominger3

  • 1Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Ismaninger Str. 22, D-81675 München, Germany.

Diagnostics (Basel, Switzerland)
|October 27, 2022
PubMed
Summary

Combining O-(2-[18F]fluoroethyl)-l-tyrosine-PET (FET-PET) and magnetic resonance spectroscopy (MRS) improves glioma grading and prognosis. Multimodal imaging offers complementary data for better characterization of brain tumors before therapy.

Keywords:
gliomamagnetic resonance imagingmagnetic resonance spectroscopymultiparametric imagingpositron emission tomography

More Related Videos

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
09:58

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Published on: November 9, 2018

7.7K
Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
09:03

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

10.2K

Related Experiment Videos

Last Updated: Aug 23, 2025

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.6K
Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
09:58

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Published on: November 9, 2018

7.7K
Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
09:03

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

10.2K

Area of Science:

  • Neuro-oncology
  • Medical imaging
  • Biophysics

Background:

  • Gliomas require accurate grading and prognostication for effective treatment planning.
  • Both O-(2-[18F]fluoroethyl)-l-tyrosine-PET (FET-PET) and 1H magnetic resonance spectroscopy (MRS) are established tools for glioma assessment.
  • The combined potential of multimodal FET-PET and MRS imaging in gliomas remains underexplored.

Purpose of the Study:

  • To evaluate the diagnostic and prognostic performance of combined FET-PET and MRS in glioma patients.
  • To determine the added value of multimodal imaging over individual techniques for glioma grading and survival prediction.
  • To explore multiparametric combinations of FET-PET and MRS parameters.

Main Methods:

  • Sixty-seven glioma patients underwent both static and dynamic FET-PET and multi-voxel 1H MRS.
  • NAA/Cr and Cho/Cr ratios from MRS and various FET-PET parameters were analyzed.
  • Receiver operating characteristic (ROC) analysis was used to assess diagnostic accuracy and survival analysis for prognostic value.

Main Results:

  • Multimodal analysis significantly improved the differentiation between low-grade and high-grade gliomas (AUC 0.97, p=0.001).
  • Dynamic FET-PET and MRS (NAA/Cr ratio) were superior to static FET-PET for distinguishing glioblastoma from non-glioblastoma (AUC 0.88 and 0.66, respectively).
  • FET-PET parameters and multimodal analysis, including MRS, were significant predictors of overall survival (OS).

Conclusions:

  • FET-PET and MRS provide complementary information for glioma characterization.
  • Multimodal imaging enhances diagnostic accuracy and prognostic capability in glioma patients.
  • This combined approach is valuable for pre-treatment characterization, especially with the rise of hybrid PET/MRI systems.